Volume 7, Issue 2 (4-2019)                   J. Pediatr. Rev 2019, 7(2): 105-112 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kazeminejad A, Hajheydari Z, Ghahari M J. Scabies Treatment in Children: A Narrative Review. J. Pediatr. Rev 2019; 7 (2) :105-112
URL: http://jpr.mazums.ac.ir/article-1-175-en.html
Scabies Treatment in Children: A Narrative Review
Armaghan Kazeminejad1 , Zohreh Hajheydari 2, Mohammad Jafar Ghahari3
1- Department of Dermatology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
2- Department of Dermatology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. , zhajheydari@yahoo.com
3- Department of Public Health, School of Health, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract:   (9116 Views)
Context: Scabies is a common infestation in children. Treatment of scabies in infants and children is a therapeutic challenge. Many prescribed drugs for adults cannot be used in children because of their side effects and safety profile. This review article studied the treatment of scabies in children and infants. 
Evidence Acquisition: In this review, electronic databases, including Google Scholar, PubMed, Cochrane and Scopus were searched based on the following MeSH terms: Scabies, Pediatric and Children. We included all articles related to scabies in children published from 2008 to 2018. Duplicated and irrelevant studies and abstracts were excluded.
Results: The management of scabies is focused on identification and treatment of cases and household contacts. We briefly discussed the clinical presentation of scabies with the currently used topical and oral treatments for this infestation. Topical treatments are effective and the most effective treatment is permethrin. Other treatment options may be less effective, poorly tolerated, or with adverse effects.
Conclusions: Scabies is prevalent in children and causes considerable morbidity. Because of its complications, scabies should be managed properly in accordance with the guidelines.
Keywords: Treatment, Scabies, Child
Full-Text [PDF 458 kb]   (4611 Downloads) |   |   Full-Text (HTML)  (12269 Views)  
Type of Study: Narrative Review | Subject: Dermatology
Received: 2018/03/17 | Accepted: 2018/06/19 | Published: 2019/04/1
References
1. Nair BK, Josph A, Kandamuthan M. Epidemic scabies. Indian Journal of Medical Research. 1977; 65(4):513-18. [PMID] [PMID]
2. Walker GJ, Johnstone P. Interventions for treating scabies. Cochrane Database of Systematic Reviews. 2007; 3:CD000320. [DOI:10.1002/14651858.CD000320.pub2] [DOI:10.1002/14651858.CD000320.pub2]
3. Andrews RM, McCarthy J, Carapetis JR, Currie BJ. Skin disorders, including pyoderma, scabies, and tinea infections. Pediatric Clinics. 2009; 56(6):1421-40. [DOI:10.1016/j.pcl.2009.09.002] [PMID] [DOI:10.1016/j.pcl.2009.09.002]
4. World Health Organization. Epidemiology and management of common skin diseases in children in developing countries. Geneva: World Health Organization; 2005.
5. Gulati PV, Singh KP, Braganza C. Role of sociocultural and environmental factors in the cause of scabies. International Journal of Dermatology. 1977; 16(4):281-3. [DOI:10.1111/j.1365-4362.1977.tb04321.x] [PMID] [DOI:10.1111/j.1365-4362.1977.tb04321.x]
6. Mimouni D, Ankol OE, Davidovitch N, Gdalevich M, Zangvil E, Grotto I. Seasonality trends of scabies in a young adult population: A 20‐year follow‐up. British Journal of Dermatology. 2003; 149(1):157-9. [DOI:10.1046/j.1365-2133.2003.05329.x] [PMID] [DOI:10.1046/j.1365-2133.2003.05329.x]
7. Service MW. Medical Entomology for Students. Cambridge: Cambridge University Press; 2007.
8. Chosidow O. Clinical practices. Scabies. The New England Journal of Medicine. 2006; 356(16):1718-27. [DOI:10.1056/NEJMcp052784] [PMID]
9. Mika A, Reynolds SL, Pickering D, McMillan D, Sriprakash KS, Kemp DJ, et al. Complement inhibitors from scabies mites promote streptococcal growth-a novel mechanism in infected epidermis? PLOS Neglected Tropical Diseases. 2012; 6(7):e1563. [DOI:10.1371/journal.pntd.0001563] [PMID] [PMCID] [DOI:10.1371/journal.pntd.0001563]
10. Chakrabarti A. Some epidemiological aspects of animal scabies in human population. International Journal of Zoonoses. 1985; 12(1):39-52. [PMID] [PMID]
11. Burgess IF. Sarcoptes scabiei and scabies. Advances in Parasitology. 1994; 33:235-43. [DOI:10.1016/S0065-308X(08)60414-5] [DOI:10.1016/S0065-308X(08)60414-5]
12. Buczek A, Pabis B, Bartosik K, Stanislawek IM, Salata M, Pabis A. Epidemiological study of scabies in diff erent environmental conditions in central Poland. Annals of Epidemiology. 2006; 16(6):423-8. [DOI:10.1016/j.annepidem.2005.06.058] [PMID] [DOI:10.1016/j.annepidem.2005.06.058]
13. Boralevi F, Diallo A, Miquel J, Guerin Moreau M, Bessis D, Chiavérini C, et al. Clinical phenotype of scabies by age. Pediatrics. 2014; 133(4):e910-6. [PMID] [DOI:10.1542/peds.2013-2880] [PMID]
14. Johnston GA. Treatment of bullous impetigo and the staphylococcal scalded skin syndrome in infants. Expert Review of Anti-Infective Therapy. 2004; 2(3):439-46. [DOI:10.1586/14787210.2.3.439] [DOI:10.1586/14787210.2.3.439]
15. Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: Clinical and immunological findings in seventy-eight patients and a review of the literature. Journal of Infection. 2005; 50(5):375-81. [DOI:10.1016/j.jinf.2004.08.033] [PMID] [DOI:10.1016/j.jinf.2004.08.033]
16. Chouela E, Abelda-o A, Pellerano G, Hernández MI. Diagnosis and treatment of scabies. American Journal of Clinical Dermatology. 2002; 3(1):9-18. [DOI:10.2165/00128071-200203010-00002] [PMID] [DOI:10.2165/00128071-200203010-00002]
17. Hulbert TV, Larsen RA. Hyperkeratotic (norwegian) scabies with gram-negative bacteremia as the initial presentation of AIDS. Clinical Infectious Diseases. 1992; 14(5):1164-5. [DOI:10.1093/clinids/14.5.1164] [DOI:10.1093/clinids/14.5.1164]
18. Currie BJ, Carapetis JR. Skin infections and infestations in Aboriginal communities in northern Australia. Australasian Journal of Dermatology. 2000; 41(3):139-43. [DOI:10.1046/j.1440-0960.2000.00417.x] [DOI:10.1046/j.1440-0960.2000.00417.x]
19. Terry BC, Kanjah F, Sahr F, Kortequee S, Dukulay I, Gbakima AA. Sarcoptes scabiei infestation among children in a displacement camp in Sierra Leone. Public Health. 2001; 115(3):208-11. [DOI:10.1016/S0033-3506(01)00445-0] [DOI:10.1016/S0033-3506(01)00445-0]
20. Hoy WE, White AV, Dowling A, Sharma SK, Bloomfield H, Tipiloura BT, et al. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney International. 2012; 81(10):1026-32. [DOI:10.1038/ki.2011.478] [PMID] [DOI:10.1038/ki.2011.478]
21. Berríos X, Lagomarsino E, Solar E, Sandoval G, Guzmán B, Riedel I. Post-streptococcal acute glomerulonephritis in Chile-20 years of experience. Pediatric Nephrology. 2004; 19(3):306-12. [DOI:10.1007/s00467-003-1340-9] [PMID] [DOI:10.1007/s00467-003-1340-9]
22. Buff M, Dupin N. Current treatments for scabies. Fundamental & Clinical Pharmacology. 2003; 17(2):217-25. [DOI:10.1046/j.1472-8206.2003.00173.x] [DOI:10.1046/j.1472-8206.2003.00173.x]
23. La Vincente S, Kearns T, Connors C, Cameron S, Carapetis J, Andrews R. Community management of endemic scabies in remote aboriginal communities of northern Australia: Low treatment uptake and high ongoing acquisition. PLoS Neglected Tropical Diseases. 2009; 3(5):e444. [DOI:10.1371/journal.pntd.0000444] [PMID] [PMCID] [DOI:10.1371/journal.pntd.0000444]
24. Wooltorton E. Concerns over lindane treatment for scabies and lice. Canadian Medical Association Journal. 2003; 168(11):1447-8. [PMID] [PMCID]
25. Flinders DC, De Schweinitz P. Pediculosis and scabies. American Family Physician. 2004; 69(2):341-8. [PMID] [PMID]
26. Purvis RS, Tyring SK. An outbreak of lindane-resistant scabies treated successfully with permethrin 5% cream. Journal of the American Academy of Dermatology. 1991; 25(6):1015-6. [DOI:10.1016/0190-9622(91)70300-Q] [DOI:10.1016/0190-9622(91)70300-Q]
27. Taplin D, Meinking TL, Porcelain SL, Athey RL, Chen JA, Castillero PM, et al. Community control of scabies: A model based on use of permethrin cream. The Lancet. 1991; 337(8748):1016-8. [DOI:10.1016/0140-6736(91)92669-S] [DOI:10.1016/0140-6736(91)92669-S]
28. Zlotkin E. The insect voltage-gated sodium channel as target of insecticides. Annual Review of Entomology. 1999; 44(1):429-55. [DOI:10.1146/annurev.ento.44.1.429] [PMID] [DOI:10.1146/annurev.ento.44.1.429]
29. Pasay C, Walton S, Fischer K, Holt D, McCarthy J. PCR-based assay to survey for knockdown resistance to pyrethroid acaricides in human scabies mites (Sarcoptes scabiei var hominis). The American Journal of Tropical Medicine and Hygiene. 2006; 74(4):649-57. [DOI:10.4269/ajtmh.2006.74.649] [PMID] [DOI:10.4269/ajtmh.2006.74.649]
30. Pasay C, Arlian L, Morgan M, Vyszenski Moher D, Rose A, Holt D, et al. High‐resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Medical and Veterinary Entomology. 2008; 22(1):82-8. [DOI:10.1111/j.1365-2915.2008.00716.x] [PMID] [DOI:10.1111/j.1365-2915.2008.00716.x]
31. Hengge UR, Currie BJ, Jäger G, Lupi O, Schwartz RA. Scabies: A ubiquitous neglected skin disease. The Lancet Infectious Diseases. 2006; 6(12):769-79. [DOI:10.1016/S1473-3099(06)70654-5] [DOI:10.1016/S1473-3099(06)70654-5]
32. Brooks PA, Grace RF. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries. Journal of Paediatrics and Child Health. 2002; 38(4):401-4. [DOI:10.1046/j.1440-1754.2002.00015.x] [DOI:10.1046/j.1440-1754.2002.00015.x]
33. Sule HM, Thacher TD. Comparison of ivermectin and benzyl benzoate lotion for scabies in Nigerian patients. The American Journal of Tropical Medicine and Hygiene. 2007; 76(2):392-5. [DOI:10.4269/ajtmh.2007.76.392] [DOI:10.4269/ajtmh.2007.76.392]
34. Glaziou P, Cartel JL, Alzieu P, Briot C, Moulia Pelat JP, Martin PM. Comparison of ivermectin and benzyl benzoate for treatment of scabies. Annals of Tropical Medicine & Parasitology. 1993; 44(4):331-2.
35. Whybrew C. Treating scabies infestations in children and adults. Prescriber. 2017; 28(5):15-20. [DOI:10.1002/psb.1568]
36. Saeedi M, Hajheydari Z, Akbari J, MortezaSemnani K, Emadian A. Preparation of malathion 0.5% Lotion and studying its effect on healing scabies compared with permethrin cream 5%. Journal of Mazandaran University of Medical Sciences. 2015; 25(129):128-31.
37. Food and Drug Administration. Labeling changes for lindane. Silver Spring, Maryland: Food and Drug Administration; 2003.
38. Boix V, Sánchez Payá J, Portilla J, Merino E. Nosocomial outbreak of scabies clinically resistant to lindane. Infection Control & Hospital Epidemiology. 1997; 18(10):677. [DOI:10.1086/647507] [PMID] [DOI:10.1086/647507]
39. Goldust M, Rezaee E, Raghifar R, Hemayat S. Treatment of scabies: The topical ivermectin vs. permethrin 2.5% cream. Annals of Parasitology. 2013; 59(2):79-84. [PMID]
40. Meinking TL, Taplin D, Herminda JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. New England Journal of Medicine. 1995; 333(1):26-30. [DOI:10.1056/NEJM199507063330105] [PMID] [DOI:10.1056/NEJM199507063330105]
41. Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. International Journal of Infectious Diseases. 1998; 2(3):152-4. [DOI:10.1016/S1201-9712(98)90118-7] [DOI:10.1016/S1201-9712(98)90118-7]
42. Galvany Rossell L, Salleras Redonnet M, Umbert Millet P. Bullous scabies responding to ivermectin therapy. Actas Dermo-Sifiliográficas. 2010; 101(1):81-4. [DOI:10.1016/j.ad.2009.05.004] [PMID] [DOI:10.1016/j.ad.2009.05.004]
43. Geary TG. Ivermectin 20 years on: Maturation of a wonder drug. Trends in Parasitology. 2005; 21(11):530-2. [DOI:10.1016/j.pt.2005.08.014] [PMID] [DOI:10.1016/j.pt.2005.08.014]
44. Nnoruka EN, Agu CE. Successful treatment of scabies with oral ivermectin in Nigeria. Tropical Doctor. 2001; 31(1):15-8. [DOI:10.1177/004947550103100105] [PMID] [DOI:10.1177/004947550103100105]
45. Mounsey KE, Dent JA, Holt DC, McCarthy J, Currie BJ, Walton SF. Molecular characterisation of a pH-gated chloride channel from Sarcoptes scabiei. Invertebrate Neuroscience. 2007; 7(3):149-56. [DOI:10.1007/s10158-007-0050-6] [PMID] [DOI:10.1007/s10158-007-0050-6]
46. L Ly F, Caumes E, Ndaw CA, Ndiaye B, Mahé A. Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: A randomized controlled trial. Bulletin of the World Health Organization. 2009; 87(6):424-30. [DOI:10.2471/BLT.08.052308] [PMID] [PMCID] [DOI:10.2471/BLT.08.052308]
47. Oladimeji FA, Orafidiya OO, Ogunniyi TA, Adewunmi TA. Pediculocidal and scabicidal properties of Lippia multiflora essential oil. Journal of Ethnopharmacology. 2000; 72(1-2):305-11. [DOI:10.1016/S0378-8741(00)00229-4] [DOI:10.1016/S0378-8741(00)00229-4]
48. Ayoub N, Merhy M, Tomb R. Treatment of scabies with albendazole. Dermatology. 2009; 218(2):175. [DOI:10.1159/000182254] [PMID] [DOI:10.1159/000182254]
49. Douri T, Shawaf AZ. Treatment of crusted scabies with albendazole: A case report. Dermatology Online Journal. 2009; 15(10):17. [PMID] [PMID]
50. Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. New England Journal of Medicine. 2010; 362(8):717-25. [DOI:10.1056/NEJMct0910329] [PMID] [DOI:10.1056/NEJMct0910329]
51. Arlian LG, Estes SA, Vyszenski Moher DL. Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients. Journal of the American Academy of Dermatology. 1988; 19(5):806-11. [DOI:10.1016/S0190-9622(88)70237-6] [DOI:10.1016/S0190-9622(88)70237-6]
52. Steer AC, Kearns T, Andrews RM, McCarthy JS, Carapetis JR, Currie BJ. Ivermectin worthy of further investigation. Bulletin of the World Health Organization. 2009; 87:A-B. [DOI:10.2471/BLT.09.070540] [DOI:10.2471/BLT.09.070540]
53. Scheinfeld N. Controlling scabies in institutional settings. American Journal of Clinical Dermatology. 2004; 5(1):31-7. [DOI:10.2165/00128071-200405010-00005] [PMID] [DOI:10.2165/00128071-200405010-00005]
54. Obasanjo OO, Wu P, Conlon M, Karanfil LV, Pryor P, Moler G, et al. An outbreak of scabies in a teaching hospital lessons learned. Infection Control & Hospital Epidemiology. 2001; 22(1):13-8. [DOI:10.1086/501818] [PMID] [DOI:10.1086/501818]
55. Andersen BM, Haugen H, Rasch M, Haugen AH, Tageson A. Outbreak of scabies in Norwegian nursing homes and home care patients: Control and prevention. Journal of Hospital Infection. 2000; 45(2):160-4. DOI:10.1053/jhin.1999.0716] [PMID] [DOI:10.1053/jhin.1999.0716]
56. Paasch U, Haustein UF. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. International Journal of Dermatology. 2000; 39(6):463-70. [DOI:10.1046/j.1365-4362.2000.00990.x] [DOI:10.1046/j.1365-4362.2000.00990.x]
57. Buehlmann M, Beltraminelli H, Strub C, Bircher A, Jordan X, Battegay M, et al. Scabies outbreak in an intensive care unit with 1,659 exposed individuals-key factors for controlling the outbreak. Infection Control & Hospital Epidemiology. 2009; 30(4):354-60. [DOI:10.1086/596113] [PMID] [DOI:10.1086/596113]
58. Yonkosky D, Ladia L, Gackenheimer L, Schultz MW. Scabies in nursing homes: An eradication program with permethrin 5% cream. Journal of the American Academy of Dermatology. 1990; 23(6):1133-6. [DOI:10.1016/0190-9622(90)70346-J] [DOI:10.1016/0190-9622(90)70346-J]
59. Sullivan JR, Watt G, Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Australasian Journal of Dermatology. 1997; 38(3):137-40. [DOI:10.1111/j.1440-0960.1997.tb01130.x] [DOI:10.1111/j.1440-0960.1997.tb01130.x]
60. Dannaoui E, Kiazand A, Piens MA, Picot S. Use of ivermectin for the management of scabies in a nursing home. European Journal of Dermatology. 1999; 9(6):443-5. [PMID]
61. Leppard B, Naburi AE. The use of ivermectin in controlling an outbreak of scabies in a prison. British Journal of Dermatology. 2000; 143(3):520-3. [DOI:10.1111/j.1365-2133.2000.03704.x] [PMID] [DOI:10.1111/j.1365-2133.2000.03704.x]
62. Chosidow O. Scabies and pediculosis. The Lancet. 2000; 355(9206):819-26. [DOI:10.1016/S0140-6736(99)09458-1] [DOI:10.1016/S0140-6736(99)09458-1]
63. Walton SF, Myerscough MR, Currie BJ. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2000; 94(1):92-6. [DOI:10.1016/S0035-9203(00)90454-1] [DOI:10.1016/S0035-9203(00)90454-1]
64. Walton SF, McKinnon M, Pizzutto S, Dougall A, Williams E, Currie BJ. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: In vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol. Archives of Dermatology. 2004; 140(5):563-6. [DOI:10.1001/archderm.140.5.563] [PMID] [DOI:10.1001/archderm.140.5.563]
65. Pasay C, Mounsey K, Stevenson G, Davis R, Arlian L, Morgan M, et al. Acaricidal activity of eugenol based compounds against scabies mites. PloS One. 2010; 5(8):e12079. [DOI:10.1371/journal.pone.0012079] [PMID] [PMCID] [DOI:10.1371/journal.pone.0012079]
66. de Almeida HL. Treatment of steroid-resistant nodular scabies with topical pimecrolimus. Journal of the American Academy of Dermatology. 2005; 53(2):357-8. [DOI:10.1016/j.jaad.2005.02.021] [PMID] [DOI:10.1016/j.jaad.2005.02.021]
67. Mittal A, Garg A, Agarwal N, Gupta L, Khare AK. Treatment of nodular scabies with topical tacrolimus. Indian Dermatology Online Journal. 2013; 4(1):52-3. [DOI:10.4103/2229-5178.105486] [DOI:10.4103/2229-5178.105486]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Pediatrics Review

Designed & Developed by : Yektaweb